Benefits of research

Lyme disease patients benefit directly from the the research done by Lyme disease research and practice (LR&P). Through LR&P, they gain access to clinical trials by the same doctors who are treating them, and they are often among the first to receive new, proven therapies for their disease. "We're leading the standard of care" says Dr. Daniel J. Cameron, a nationally renowned expert in the Lyme disease field who is director of the Lyme Disease Research and Practice.

Dr. Cameron takes leadership roles in an international Lyme disease society called ILADS. Dr. Cameron is the lead author of a recently peer reviewed published treatment guideline for Lyme disease. This treatment guideline used used evidence based medicine in Lyme disease patients. These guidelines have become a standard of care in the treatment of Lyme disease.

These guidelines were developed by 17 professionals around the country and was sponsered by the International Lyme and Associated Disease Society (ILADS), a nonprofit, international, multidisciplinary medical society, dedicated to the diagnosis and appropriate treatment of Lyme and its associated diseases. The guidelines were published in the 2004 edition of Expert Rev. Anti-infect. Ther. 2(1).